Astromech
Summary active Updated May 26, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Astromech is a Dallas-based AI-biotech company spun out of Colossal Biosciences, building a predictive engine for biology that aims to forecast evolution, disease risk, and system vulnerabilities before they happen 1. Co-founded by Ben Lamm and Harvard geneticist George Church, the company initially raised $30 million in seed funding in September 2025 2. A $10.5 million seed extension brought total funding to $40.5 million, with the company reaching a reported $2 billion valuation just nine months after spin-out 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2025-09-23 | Seed | $30M | Undisclosed | Undisclosed 23 |
| 2026-03 | Seed Extension (per D Magazine reporting) | $10.5M | Undisclosed | Undisclosed 1 |
What Investors Say
No verified investor quotes available at this time.
What Founders Say
No verified founder quotes available at this time.
Sources
-
D CEO Magazine, “Astromech, the New AI Startup from Ben Lamm of Colossal Biosciences,” March 2026. https://www.dmagazine.com/business-economy/2026/03/ben-lamm-astromech-colossal/↩↩↩
-
FinSMEs, “Ben Lamm Teams with George Church for $30M AI Company Astromech,” September 2025. https://www.finsmes.com/2025/09/ben-lamm-teams-with-george-church-for-30m-ai-company-astromech.html↩↩
-
Yahoo Finance, “Ben Lamm’s Astromech Secures $30 Million to Advance AI-Biotechnology Innovation,” September 23, 2025. Accessed May 2026. https://finance.yahoo.com/news/ben-lamms-astromech-secures-30-174000113.html↩